Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,415 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

NCT01048034

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
Locations
  • Department of Hematology, Aalborg University Hospital Aalborg, Denmark
  • Department of Hematology, Aarhus Univsersity Hospital Aarhus, Denmark
  • Department of Hematology, Rigshospitalet Univsersity Hospital Copenhagen, Denmark
  • Department of Hematology, Herlev Hospital Herlev, Denmark
View all 17 locations
View Trial Details
Completed

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients

NCT00949741

Conditions
Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +22 more
Locations
  • ASO SS Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy
  • PO Centro Binaghi Divisione di Ematologia CTMO Cagliari, CA, Italy
  • Az. Ospedaliero Universitaria Careggi Florence, FI, Italy
  • Ospedale Vito Fazzi Divisione di Ematologia Lecce, LE, Italy
View Trial Details
Completed

Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

NCT00333840

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Montgomery, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Berkeley, California, United States
View all 163 locations
View Trial Details
Completed

Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00068315

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mercy Medical Center Canton, Ohio, United States
  • Case Western Reserve University Cleveland, Ohio, United States
  • Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Southwest General Health Center Ireland Cancer Center Middleburg Heights, Ohio, United States
View Trial Details

Related conditions